Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SR-89' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 175 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ferrero-Pous, M; Hersant, AM; Pecking, A; Bresard-Leroy, M; Pichon, MF
      Serum chromogranin-A in advanced prostate cancer

      BJU INTERNATIONAL
    2. Pauwels, EKJ; Stokkel, MPM
      Radiopharmaceuticals for bone lesions - Imaging and therapy in clinical practice

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    3. Giammarile, F; Mognetti, T; Resche, I
      Bone pain palliation with Strontium-89 in cancer patients with bone metastases

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    4. Han, SH; De Klerk, JMH; Zonnenberg, BA; Tan, S; Van Rijk, PP
      Re-186-Etidronate - Efficacy of palliative radionuclide therapy for painful bone metastases

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    5. Piffanelli, A; Dafermou, A; Giganti, M; Colamussi, P; Pizzocaro, C; Bestagno, M
      Radionuclide therapy for painful bone metastases - An Italian multicentre observational study

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    6. Reale, C; Turkiewicz, AM; Reale, CA
      Antalgic treatment of pain associated with bone metastases

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    7. Kinoshita, A; Braga, FJHN; Graeff, CFO; Baffa, O
      ESR dosimetry of Sr-89 and Sm-153 in bone

      APPLIED RADIATION AND ISOTOPES
    8. Hong, KH; Cho, YH; Lee, MH; Choi, GS; Lee, CW
      Simultaneous measurement of Sr-89 and Sr-90 in aqueous samples by liquid scintillation counting using the spectrum unfolding method

      APPLIED RADIATION AND ISOTOPES
    9. Davis, J; Pither, RJ
      Biochemical responses in cultured cells following exposure to (SrCl2)-Sr-89: potential relevance to the mechanism of action in pain palliation

      EUROPEAN JOURNAL OF CANCER
    10. Windsor, PM
      Predictors of response to strontium-89 (Metastron (R)) in skeletal metastases from prostate cancer: Report of a single centre's 10-year experience

      CLINICAL ONCOLOGY
    11. Hoskin, PJ; Yarnold, JR; Roos, DR; Bentzen, S
      Radiotherapy for bone metastases

      CLINICAL ONCOLOGY
    12. Silberstein, EB
      Painful osteoblastic metastases: The role of nuclear medicine

      ONCOLOGY-NEW YORK
    13. Enke, CA
      Painful osteoblastic metastases: The role of nuclear medicine - The Silberstein article reviewed

      ONCOLOGY-NEW YORK
    14. Berenson, JR
      Painful osteoblastic metastases: The role of nuclear medicine - The Silberstein article reviewed

      ONCOLOGY-NEW YORK
    15. Sun, SS; Tsai, SC; Hsieh, JF; Lee, JK; Kao, CH
      Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma

      CLINICAL NUCLEAR MEDICINE
    16. Dafermou, A; Colamussi, P; Giganti, M; Cittanti, C; Bestagno, M; Piffanelli, A
      A multicentre observational study of radionuclide therapy in patients withpainful bone metastases of prostate cancer

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    17. Oyen, WJG; Witjes, JA; Corstens, FHM
      Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma

      EUROPEAN UROLOGY
    18. Sciuto, R; Festa, A; Pasqualoni, R; Semprebene, A; Rea, S; Bergomi, S; Maini, CL
      Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients

      BREAST CANCER RESEARCH AND TREATMENT
    19. Serafini, AN
      Therapy of metastatic bone pain

      JOURNAL OF NUCLEAR MEDICINE
    20. Turner, SL; Gruenewald, S; Spry, N; Gebski, V
      Less pain does equal better quality of life following strontium-89 therapyfor metastatic prostate cancer

      BRITISH JOURNAL OF CANCER
    21. Jager, PL; Kooistra, A; Piers, DA
      Treatment with radioactive (89)strontium for patients with bone metastasesfrom prostate cancer

      BJU INTERNATIONAL
    22. Liepe, K; Hliscs, R; Kropp, J; Gruning, T; Runge, R; Koch, R; Knapp, FF; Franke, WG
      Rhenium-188-HEDP in the palliative treatment of bone metastases

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    23. Silberstein, EB
      Systemic radiopharmaceutical therapy of painful osteoblastic metastases

      SEMINARS IN RADIATION ONCOLOGY
    24. McEwan, AJB
      Use of radionuclides for the palliation of bone metastases

      SEMINARS IN RADIATION ONCOLOGY
    25. Kucuk, NO; Ibis, E; Aras, G; Baltaci, S; Ozalp, G; Beduk, Y; Canakci, N; Soylu, A
      Palliative analgesic effect of Re-186HEDP in various cancer patients with bone metastases

      ANNALS OF NUCLEAR MEDICINE
    26. Liepe, K; Kropp, J; Hliscs, R; Franke, WG
      Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy

      CLINICAL NUCLEAR MEDICINE
    27. Palmedo, H; Guhlke, S; Bender, H; Sartor, J; Schoeneich, G; Risse, J; Grunwald, F; Knapp, FF; Biersack, HJ
      Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    28. Kraeber-Bodere, F; Campion, L; Rousseau, C; Bourdin, S; Chatal, JF; Resche, I
      Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    29. Giannakenas, C; Kalofonos, HP; Apostolopoulos, DJ; Zarakovitis, J; Kosmas, C; Vassilakos, PJ
      Preliminary results of the use of Re-186-HEDP for palliation of pain in patients with metastatic bone disease

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    30. Kalkner, KM; Westlin, JE; Strang, P
      (89)strontinm in the management of painful sceletal metastases

      ANTICANCER RESEARCH
    31. Papatheofanis, FJ
      Decreased serum E-selectin concentration after Sr-89-chloride therapy for metastatic prostate cancer bone pain

      JOURNAL OF NUCLEAR MEDICINE
    32. Sciuto, R; Tofani, A; Festa, A; Giannarelli, D; Pasqualoni, R; Maini, CL
      Short- and long-term effects of Re-186-1,1-hydroxyethylidene diphosphonatein the treatment of painful bone metastases

      JOURNAL OF NUCLEAR MEDICINE
    33. Davis, J; Cook, ND; Pither, RJ
      Biologic mechanisms of (SrCl2)-Sr-89 incorporation into type I collagen during bone mineralization

      JOURNAL OF NUCLEAR MEDICINE
    34. Fuster, D; Herranz, R; Vidal-Sicart, S; Munoz, M; Conill, C; Mateos, JJ; Martin, F; Pons, F
      Usefulness of strontium-89 for bone pain palliation in metastatic breast cancer patients

      NUCLEAR MEDICINE COMMUNICATIONS
    35. Tennvall, J; Abrahamsson, PA; Ahlgren, G; Darte, L; Flodgren, P; Garkavij, M; Strand, SE
      Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinoma

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    36. Akerley, W
      Secondary leukemia - Twice is a coincidence?

      CANCER
    37. Kossman, SE; Weiss, MA
      Acute myelogenous leukemia after exposure to strontium-89 for the treatment of adenocarcinoma of the prostate

      CANCER
    38. Liepe, K; Franke, WG; Kropp, J; Koch, R; Runge, R; Hliscs, R
      Comparison of Rhenium-188, Rhenium-186-HEDP and Strontium-89 in palliationof painful bone metastases

      NUKLEARMEDIZIN-NUCLEAR MEDICINE
    39. Hsieh, BT; Hsieh, JF; Tsai, SC; Lin, WY; Wang, SJ; Ting, G
      Comparison of various rhenium-188-labeled diphosphonates for the treatmentof bone metastases

      NUCLEAR MEDICINE AND BIOLOGY
    40. Lin, WY; Hsieh, JF; Lin, CP; Hsieh, BT; Ting, G; Wang, SJ; Knapp, FF
      Effect of reaction conditions on preparations of Rhenium-188 hydroxyethylidene diphosphonate complexes

      NUCLEAR MEDICINE AND BIOLOGY
    41. Wendt, K; Blaum, K; Bushaw, BA; Gruning, C; Horn, R; Huber, G; Kratz, JV; Kunz, P; Muller, P; Nortershauser, W; Nunnemann, M; Passler, G; Schmitt, A; Trautmann, N; Waldek, A
      Recent developments in and applications of resonance ionization mass spectrometry

      FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
    42. Trachtenberg, J; Crook, J; Tannock, IF
      Prostate cancer: 11. Alternative approaches and the future of treatment

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    43. Iscoe, NA; Bruera, E; Choo, RC
      Prostate cancer: 10. Palliative care

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    44. Palmedo, H; Bender, H; Dierke-Dzierzon, C; Carl, UM; Risse, J; Krebs, D; Biersack, HJ
      Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases

      CLINICAL NUCLEAR MEDICINE
    45. Paszkowski, AL; Hewitt, DJ; Taylor, A
      Disseminated intravascular coagulation in a patient treated with strontium-89 for metastatic carcinoma of the prostate

      CLINICAL NUCLEAR MEDICINE
    46. Joensuu, H; Tenhunen, M
      Physical and biological targeting of radiotherapy

      ACTA ONCOLOGICA
    47. Grahek, Z; Kosuic, K; Lulic, S
      Improved method for the separation of radioactive strontium from various samples by mixed solvent anion exchange

      JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
    48. Grahek, Z; Eskinja, I; Kosutic, K; Lulic, S; Kvastek, K
      Isolation of radioactive strontium from natural samples: A semi-automatic procedure

      JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
    49. Papatheofanis, FJ
      Variation in oncologic opinion regarding management of metastatic bone pain with systemic radionuclide therapy

      JOURNAL OF NUCLEAR MEDICINE
    50. Han, SH; Zonnenberg, BA; de Klerk, JMH; Quirijnen, JMSP; Schip, ADVH; van Dijk, A; Blijham, GH; van Rijk, PP
      Re-186-etidronate in breast cancer patients with metastatic bone pain

      JOURNAL OF NUCLEAR MEDICINE
    51. Geldof, AA; de Rooij, L; Versteegh, RT; Newling, DWW; Teule, GJJ
      Combination Re-186-HEDP and cisplatin supra-additive treatment effects in prostate cancer cells

      JOURNAL OF NUCLEAR MEDICINE
    52. Nair, N
      Relative Efficacy of P-32 and Sr-89 in palliation in Skeletal metastases

      JOURNAL OF NUCLEAR MEDICINE
    53. Syed, GMS; Maken, RN; Muzzaffar, N; Shah, MA; Rana, F
      Effective and economical option for pain palliation in prostate cancer with skeletal metastases: P-32 therapy revisited

      NUCLEAR MEDICINE COMMUNICATIONS
    54. Friedland, J
      Local and systemic radiation for palliation of metastatic disease

      UROLOGIC CLINICS OF NORTH AMERICA
    55. Chang, HM
      Cancer pain management

      MEDICAL CLINICS OF NORTH AMERICA
    56. Volkert, WA; Hoffman, TJ
      Therapeutic radiopharmaceuticals

      CHEMICAL REVIEWS
    57. Maublant, J; Resche, I; Giammarile, F; Corone, C; Artus, JC
      News on nuclear oncology

      BULLETIN DU CANCER
    58. Grahek, Z; Zecevic, N; Lulic, S
      Possibility of rapid determination of low-level Sr-90 activity by combination of extraction chromatography separation and Cherenkov counting

      ANALYTICA CHIMICA ACTA
    59. Grate, JW; Fadeff, SK; Egorov, O
      Separation-optimized sequential injection method for rapid automated analytical separation of Sr-90 in nuclear waste

      ANALYST
    60. Fischer, M
      Guidelines for radionuclide therapy in painful osseous metastasis

      NUKLEARMEDIZIN
    61. DeNardo, GL
      Bone pain palliation

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    62. McEwan, AJB
      Palliative therapy with bone seeking radiopharmaceuticals

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    63. SRIVASTAVA SC; ATKINS HL; KRISHNAMURTHY GT; ZANZI I; SILBERSTEIN EB; MEINKEN G; MAUSNER LF; SWAILEM F; DALESSANDRO T; CABAHUG CJ; LAU Y; PARK T; MADAJEWICZ S
      TREATMENT OF METASTATIC BONE PAIN WITH TIN-117M STANNIC DIETHYLENETRIAMINEPENTAACETIC ACID - A PHASE I II CLINICAL-STUDY/

      Clinical cancer research
    64. SRIVASTAVA SC; ATKINS HL; KRISHNAMURTHY GT; ZANZI I; SILBERSTEIN EB; MEINKEN G; MAUSNER LF; SWAILEM F; DALESSANDRO T; CABAHUG CJ; LAU Y; PARK T; MADAJEWICZ S
      TREATMENT OF METASTATIC BONE PAIN WITH TIN-117M STANNIC DIETHYLENETRIAMINEPENTAACETIC ACID - A PHASE I II CLINICAL-STUDY/

      Clinical cancer research
    65. GORDON RL
      PROLONGED CENTRAL INTRAVENOUS KETOROLAC CONTINUOUS-INFUSION IN A CANCER-PATIENT WITH INTRACTABLE BONE PAIN

      The Annals of pharmacotherapy
    66. SCHIMA FJ
      DECAY OF SR-89 AND THE EMISSION PROBABILITY OF THE 909.12 KEV GAMMA-RAY TRANSITION

      Applied radiation and isotopes
    67. ATKINS HL
      OVERVIEW OF NUCLIDES FOR BONE PAIN PALLIATION

      Applied radiation and isotopes
    68. ZIMMERMAN BE; CESSNA JT; SCHIMA FJ
      THE STANDARDIZATION OF THE POTENTIAL BONE PALLIATION RADIOPHARMACEUTICAL SN-117M(+4)DTPA

      Applied radiation and isotopes
    69. COURSEY BM; SCHIMA FJ; GOLAS DB; PALABRICA OT; SUZUKI A; DELL MA
      MEASUREMENT STANDARDS FOR SR-89 FOR USE IN BONE PALLIATION

      Applied radiation and isotopes
    70. REALE C; TURKIEWICZ AM; LUZI M; REALE CA; BARTOLOTTA G
      ANTALGIC TREATMENT OF PAIN ASSOCIATED WITH BONE METASTASES

      Annals of oncology
    71. SERAFINI AN; HOUSTON SJ; RESCHE I; QUICK DP; GRUND FM; ELL PJ; BERTRAND A; AHMANN FR; ORIHUELA E; REID RH; LERSKI RA; COLLIER BD; MCKILLOP JH; PURNELL GL; PECKING AP; THOMAS FD; HARRISON KA
      PALLIATION OF PAIN ASSOCIATED WITH METASTATIC BONE CANCER USING SM-153 LEXIDRONAM - A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL

      Journal of clinical oncology
    72. NOSETOGAWA N; KUME K; TOKI H
      ENERGY-DEPENDENCE OF THE C-12,C-14(P,PI(-))O-13,15(G.S.). REACTIONS IN A 2-NUCLEON MODEL

      Physical review. C. Nuclear physics
    73. PALMEDO H; GRUNWALD F; WAGNER U; KOHLER S; KREBS D; BIERSACK HJ
      REMISSION OF BONE METASTASES AFTER COMBINED CHEMOTHERAPY AND RADIONUCLIDE THERAPY WITH RE-186 HEDP

      Clinical nuclear medicine
    74. BENJOSEF E; SHAMSA F; WILLIAMS AO; PORTER AT
      RADIOTHERAPEUTIC MANAGEMENT OF OSSEOUS METASTASES - A SURVEY OF CURRENT PATTERNS OF CARE

      International journal of radiation oncology, biology, physics
    75. KASALICKY J; KRAJSKA V
      THE EFFECT OF REPEATED SR-89 CHLORIDE THERAPY ON BONE PAIN PALLIATIONIN PATIENTS WITH SKELETAL CANCER METASTASES

      European journal of nuclear medicine
    76. SCHOENEICH G; MULLER SC; PALMEDO H
      INDICATION FOR NUCLEAR-MEDICINE THERAPY I N ADVANCED CANCER OF THE PROSTATE

      Der Urologe
    77. KALKNER KM; WESTLIN JE; NILSSON S; STRANG P
      PAIN FIGURES ARE UNSUITABLE FOR THE DETERMINATION OF PALLIATIVE RADIOTHERAPY PORTALS IN PATIENTS WITH HORMONE-REFRACTORY PROSTATIC-CANCER

      Anticancer research
    78. NIELSEN OS; BENTZEN SM; SANDBERG E; GADEBERG CC; TIMOTHY AR
      RANDOMIZED TRIAL OF SINGLE-DOSE VERSUS FRACTIONATED PALLIATIVE RADIOTHERAPY OF BONE METASTASES

      Radiotherapy and oncology
    79. Watanabe, N; Yokoyama, K; Kinuya, S; Shuke, N; Shimizu, M; Michigishi, T; Tonami, N; Seto, H; Goodwin, DA
      Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay

      JOURNAL OF NUCLEAR MEDICINE
    80. ANDO A; ANDO I; TONAMI N; KINUYA S; KAZUMA K; KATAIWA A; NAKAGAWA M; FUJITA N
      LU-177-EDTMP - A POTENTIAL THERAPEUTIC BONE AGENT

      Nuclear medicine communications
    81. Filss, M; Botsch, W; Handl, J; Michel, R; Slavov, VP; Borschtschenko, VV
      A fast method for the determination of strontinm-89 and strontium-90 in environmental samples and its application to the analysis of strontium-90 in Ukrainian soils

      RADIOCHIMICA ACTA
    82. BAZIOTIS N; YAKOUMAKIS E; ZISSIMOPOULOS A; GERONICOLATRAPALI X; MALAMITSI J; PROUKAKIS C
      SR-89 CHLORIDE IN THE TREATMENT OF BONE METASTASES FROM BREAST-CANCER

      Oncology
    83. MERTENS WC; FILIPCZAK LA; BENJOSEF E; DAVIS LP; PORTER AT
      SYSTEMIC BONE-SEEKING RADIONUCLIDES FOR PALLIATION OF PAINFUL OSSEOUSMETASTASES - CURRENT CONCEPTS

      Ca
    84. BIALKOWSKI MM; WIERZBICKI JG; PORTER AT
      MODELING OF INTERNAL DOSE DISTRIBUTIONS DURING SR-89 TREATMENT OF A PATIENT WITH BONE METASTASES

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    85. ZUBILLAGA MB; BOCCIO JR; NICOLINI JO; UGHETTI R; LANARI E; CARO RA
      PIROCARBOTRAT(TM) - A NEW RADIOPHARMACEUTICAL FOR THE TREATMENT OF SOLID TUMORS - COMPARATIVE-STUDIES IN N-NITROSOMETHYLUREA-INDUCED RAT MAMMARY-TUMORS

      Nuclear medicine and biology
    86. KALKNER KM; GINMAN C; NILSSON S; BERGSTROM M; ANTONI G; AHLSTROM H; LANGSTROM B; WESTLIN JE
      POSITRON EMISSION TOMOGRAPHY (PET) WITH C-11 5-HYDROXYTRYPTOPHAN (5-HTP) IN PATIENTS WITH METASTATIC HORMONE-REFRACTORY PROSTATIC ADENOCARCINOMA

      Nuclear medicine and biology
    87. WENDT K; KRATZ JV; LANTZSCH J; MULLER P; NORTERSHAUSER W; SEIBERT A; TRAUTMANN N; WALDEK A; ZIMMER K
      RAPID ULTRATRACE DETERMINATION OF SR-89,SR-90 IN ENVIRONMENTAL-SAMPLES BY COLLINEAR LASER RESONANCE IONIZATION SPECTROMETRY

      Kerntechnik
    88. TAIT D; HAASE G; WIECHEN A
      A FAST METHOD FOR THE DETERMINATION OF SR-90 IN LIQUID MILK BY SOLID-PHASE EXTRACTION WITH CRYPTAND-222 ON CATION-EXCHANGE RESIN

      Kerntechnik
    89. BENJOSEF E; PORTER AT
      RADIOISOTOPES IN THE TREATMENT OF BONE METASTASES

      Annals of medicine
    90. BUSHAW BA; CANNON BD
      DIODE-LASER BASED RESONANCE IONIZATION MASS-SPECTROMETRIC MEASUREMENTOF SR-90

      Spectrochimica acta, Part B: Atomic spectroscopy
    91. SCHOENEICH G; PALMEDO H; HEIMBACH D; BIERSACK HJ; MULLER SC
      ADVANCED PROSTATE-CANCER - SYSTEMIC RADIOPHARMACEUTICAL THERAPY OF METASTATIC PROSTATE-CANCER WITH RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE

      Onkologie
    92. UCHIYAMA M; NARITA H; MAKINO M; SEKINE H; MORI Y; FUKUMITSU N; KAWAKAMI K
      SR-89 THERAPY AND IMAGING WITH BREMSSTRAHLUNG IN BONE METASTASES

      Clinical nuclear medicine
    93. POWSNER RA; ZIETMAN AL; FOSS FM
      BONE-MARROW SUPPRESSION AFTER SR-89 THERAPY AND LOCAL RADIATION-THERAPY IN PATIENTS WITH DIFFUSE MARROW INVOLVEMENT

      Clinical nuclear medicine
    94. LIN WY; LIN CP; YEH SJ; HSIEH BT; TSAI ZT; TING G; YEN ZC; WANG SJ; KNAPP FF; STABIN MF
      RE-188 HYDROXYETHYLIDENE DIPHOSPHONATE - A NEW GENERATOR-PRODUCED RADIOTHERAPEUTIC DRUG OF POTENTIAL VALUE FOR THE TREATMENT OF BONE METASTASES

      European journal of nuclear medicine
    95. CIPRIANI C; ATZEI G; ARGIRO G; BOEMI S; SHUKLA S; ROSSI G; SEDDA AF
      GAMMA-CAMERA IMAGING OF OSSEOUS METASTATIC LESIONS BY SR-89 BREMSSTRAHLUNG

      European journal of nuclear medicine
    96. HEEG MJ; DEUTSCH KF; DEUTSCH E
      THE PLACEBO-EFFECT

      European journal of nuclear medicine
    97. PONS F; HERRANZ R; GARCIA A; VIDALSICART S; CONILL C; GRAU JJ; ALCOVER J; FUSTER D; SETOAIN J
      SR-89 FOR PALLIATION OF PAIN FROM BONE METASTASES IN PATIENTS WITH PROSTATE AND BREAST-CANCER

      European journal of nuclear medicine
    98. HOLLE LH; HUMKE U; TRAMPERT L; ZIEGLER M; KIRSCH CM; OBERHAUSEN E
      PALLIATIVE TREATMENT OF PAINFUL OSSEOUS M ETASTASES IN PROSTATE CARCINOMA WITH THE OSTEOTROPIC BETA-EMITTER RHENIUM-186-HEDP

      Der Urologe
    99. PIZZOCARO C; PANAROTTO MB; DEAGOSTINI A; PAGLIAINI R; BESTAGNO M
      EXPERIENCE WITH 89-STRONTIUM TREATMENT OF PAINFUL OSSEOUS METASTASES FROM BREAST-CANCER

      Tumori
    100. GOETHUYS H; BAERT L; VANPOPPEL H; LIESKOVSKY G; BRADY LW; PETROVICH Z
      TREATMENT OF METASTATIC CARCINOMA OF THE PROSTATE

      American journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 17:49:42